Polymorphism and pseudopolymorphism of salicaine and salicaine hydrochloride crystal polymorphism of local anaesthetic drugs, part V

Journal of Pharmaceutical Sciences

Volumn 95, Issue 5, 2006, Pages 1097-1113

  Schmidt, A C ^a   Schwarz, I ^a   Mereiter, K ^b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b VIENNA UNIVERSITY OF TECHNOLOGY   (Austria)

Author keywords

Conformational polymorphism; Crystal forms; Crystal structure; Hydroxytetracaine hydrochloride; Local anaesthetics; Salicaine hydrochloride; Solid state properties; Sorption; Thermal analysis; X ray diffractometry

Indexed keywords

ALCOHOL; HYDROXYTETRACAINE; LOCAL ANESTHETIC AGENT; ORGANIC SOLVENT; SALICAINE HYDROCHLORIDE; UNCLASSIFIED DRUG; WATER;

ARTICLE; CRYSTAL STRUCTURE; CRYSTALLIZATION; DEHYDRATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG STABILITY; DRUG STRUCTURE; FREEZE DRYING; INFRARED SPECTROSCOPY; KINETICS; MELTING POINT; MOISTURE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RAMAN SPECTROMETRY; ROOM TEMPERATURE; THERMAL ANALYSIS; THERMODYNAMICS; THERMOGRAVIMETRY; WATER VAPOR; X RAY CRYSTALLOGRAPHY; X RAY POWDER DIFFRACTION;

EID: 33646550583     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20533     Document Type: Note

References (27)

1. Geddes IC. 1956. Local anesthetic properties and toxicity of hydroxyprocaine and hydroxyamethocaine. Br J Anesth 28:55-66.
2. Hekneby M. 1955. A new local anesthetic for dental use. A solution of the diethylaminoethyl ester of 4-aminosalicylic acid and the dimethylaminoethyl ester of 4-butylaminosalicylic acid ("oxyprocaine forte"). Excerpta Medica Section 2: Physiol Biochem Pharmacol 8:801.
3. Holler W. 1952. The toxicity of some local anesthetics and the effects of vasoconstrictors on the toxicity. Deut Zahnarztl Z 7:1198-1204.
4. Schmidt AC, Niederwanger V, Griesser UJ. 2004. Crystal polymorphism of local anaesthetic drugs, part II: Solid state forms of prilocaine hydrochloride. J Therm Anal Cal 77:639-652.
5. Hanson AW, Rohrl M. 1972. Crystal structure of lidocaine hydrochloride monohydrate. Acta Cryst B28:3567-3571.
6. Csöregh I. 1992. Structures and absolute configurations of enantiomers of two local anaesthetics: (2S)-1-methyl- and (2R)-1-butyl-2′, 6′-pipecoloxylidide hydrochlorides. Acta Cryst C48:1794-1798.
7. Bruins HJ, Behm HJ, Kerkkamp HEM. 1990. Structures of the local anaesthetics ropivacaine and bupivacaine: structure determination and molecular-modelling study. Acta Cryst B 46:842-850.
8. Schmidt AC. 2005. Solid state characterization of chloroprocaine hydrochloride. Crystal polymorphism of local anaesthetic drugs, part VI. J Therm Anal Cal 81:291-297.
9. Schmidt AC. 2005. Structural characteristics and crystal polymorphism of three local anaesthetic bases. Crystal polymorphism of local anaesthetic drugs, part VII. Int J Pharm 298:186-197.
10. Schmidt AC. 2005. Solid state characterisation of falicaine hydrochloride and isomorphic dyclonine hydrochloride. Crystal polymorphism of local anaesthetic drugs, part IV. Eur J Pharm Sci 25:407-416.
11. Giron D, Draghi M, Goldbronn C, Pfeffer S, Piechon P. 1997. Study of the polymorphic behaviour of some local anaesthetic drugs. J Therm Anal 49:913-927.
12. Brandstatter M, Grimm H. 1956. Polymorphism of organic compounds. Microchim Acta 7:1175-1182.
13. Schmidt AC, Schwarz I. 2005. Solid state characterization of hydroxyprocaine hydrochloride. Crystal polymorphism of local anaesthetic drugs, part VIII. J Mol Struct 148:153-160.
14. Schmidt AC. 2005. The role of molecular structure in the crystal polymorphism of local anaesthetic drugs. Crystal polymorphism of local anaesthetic drugs, part X. Pharm Res 22:2121-2133.
15. Dexter DD. 1972. Procaine: A comparative study of two independent structure determinations; conformations in different solid-state environments. Acta Crystallogr B28:77-82.
16. Schmidt AC, Griesser UJ, Brehmer T, Harris RK, King A. 2002. Conformational polymorphism of the local anaesthetic drug oxybuprocaine hydrochloride. Acta Crystallogr A58:C140.
17. Nowell H, Attfield JP, Cole JC, Cox PJ, Shankland K, Maginn SJ, Motherwell WDS. 2002. Structure solution and refinement of tetracaine hydrochloride from X-ray powder diffraction data. New J Chem 26:469-472.
18. Brandstatter-Kuhnert M, Grimm H. 1957. Identification of local anesthetics. Microchim Acta 3:427-447.
19. Bruker AXS. 2001. Programs SMART, version 5.054; SAINT, version 6.2.9; SADABS version 2.10; XPREP, version 5.1; SHELXTL, version 5.1. Bruker AXS, Inc., Madison, Wisconsin, USA.
20. Sheldrick GM. 1997. Programs SHELXS97 and SHELXL97. University of Göttingen, Germany.
21. CCDC 213315, 213316 and 277911 contain the supplementary crystallographic data for this paper. These data can be obtained free of charge via www.ccdc.cam.ac.uk/data_request/cif, by emailing data_request@ccdc.cam.ac.uk, or by contacting The Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge CB2 1EZ, UK; fax: +44 1223 336033.
22. Bernstein J, Davey RJ, Henck JO. 1999. Concomitant polymorphs. Angew Chem In Ed 38:3440-3461.
23. Burger A, Ramberger R. 1979. On the polymorphism of pharmaceuticals and other molecular crystals. I. Mikrochim Acta II 2:273-316.
24. Burger A, Ramberger R. 1979. On the polymorphism of pharmaceuticals and other molecular crystals. II. Mikrochim Acta II 2:259-271.
25. Stephenson GA, Groleau EG, Kleemann RL, Xu W, Rigsbee DR. 1998. Formation of isomorphic desolvates: Creating a molecular vacuum. J Pharm Sci 87:536-542.
26. Grunenberg A, Henck JO, Siesler HW. 1996. Theoretical derivation and practical application of energy/temperature diagrams as an instrument in preformulation studies of polymorphic drug substances. Int J Pharm 129:147-158.
27. Yu L. 1995. Inferring thermodynamic stability relationship of polymorphs from melting data. J Pharm Sci 84:966-974.